Aksìa Group buys medical packaging maker Lameplast

The company's founders and previous owners – Giovanni Ferrari, Antonio Fontana and Evro Fabbri – will maintain their positions on the company's management board.

According to a statement, the GP intends to invest in product development, focusing on certain market niches, including vaccines, nutraceuticals, luxury cosmetics and surgery.

Debt
To support the transaction, Italian bank Monte dei Paschi di Siena led a €21.5m syndicated debt package, alongside BPER Banca, Cariparma and GE Capital.

Separatley, the Italian investment firm Equita Sim provided a €5m senior bond over two tranches to Schema, the holding company of Lameplast. The deal marked the first transaction for the GP's maiden vehicle Equita Private Debt Fund.

Company
Founded in 1976 and headquartered in Modena, Lameplast produces single- and multi-dose containers for the pharmaceutical and cosmetics industry. The company manages the subsidiaries COC Farmaceutici and LF of America, and has a presence in both Italy and the US.

Lameplast generated €45m of revenues in 2015.

People
Aksìa Group – Nicola Emanuele (partner).
Lameplast – Giovanni Ferrari (chair, CEO).
Equita Sim – Alessandro Profumo (chair); Paolo Pendenza (head of private debt).

Advisers
Equity – Accinni Cartolano & Associati (legal); Global Strategy (commercial due diligence); Deloitte (financial due diligence); Studio Russo De Rosa (tax); Fineurop Soditic (debt advisory).
Vendor – NPV Europe (M&A); Studio Mariani Marazzi Vincenzi (legal); Studio Azeta (tax).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Healthcare
• Southern Europe
• Italy